Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment
Top Cited Papers
- 1 January 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in PharmacoEconomics
- Vol. 24 (4), 355-371
- https://doi.org/10.2165/00019053-200624040-00006
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux DiseaseMedical Decision Making, 2002
- Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux DiseaseMedical Decision Making, 2002
- Long Term Treatment of Multiple Sclerosis with Interferon-?? May Be Cost EffectivePharmacoEconomics, 2000
- Assessing Quality in Decision Analytic Cost-Effectiveness ModelsPharmacoEconomics, 2000
- Decision Analytic Modelling in the Economic Evaluation of Health TechnologiesPharmacoEconomics, 2000
- Systematic validation of disease models for pharmacoeconomic evaluationsJournal of Evaluation in Clinical Practice, 1999
- Panel 2: Methodological Issues in Conducting Pharmacoeconomic Evaluations—Modeling StudiesValue in Health, 1999
- Health and Economic Outcomes Modeling Practices: A Suggested FrameworkValue in Health, 1998
- Reporting Format for Economic EvaluationPharmacoEconomics, 1998
- Analysing clinical decision analysesStatistics in Medicine, 1990